EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
The 78th World Health Assembly agrees to extend the Global Action Plan on the Public Health Response to Dementia
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Guidelines for dementia failing to consider the needs of minority populations
Researchers from University College London (UCL) summarise their recently published study which explores the consideration of minority characteristics within pre-existing clinical practice guidelines for dementia.
ADI and WW-FINGERS renew commitment to work together to reduce the global risk of dementia
ADI is pleased to announce the formalisation of a long-standing collaboration with World Wide-FINGERS (WW-FINGERS) by joining in partnership to reduce the risk of dementia worldwide.
Forward with Dementia: Improving post-diagnostic support
In this blog from Meredith Gresham of COGNISANCE, Meredith outlines how the Forward with Dementia campaign is helping to provide hope and support for people living with dementia and carers, as well as tools for more effective post-diagnostic support, in 5 countries.
The built environment and national dementia plans
In this blog, the World Alzheimer Report 2020 authors discuss the creation of a new national dementia plan guide which aims to aid policymakers and interested people looking to include dementia-related design in their own national dementia plans.
The journey of ADI Accreditation
In this blog, Amalia Fonk-Utomo writes about her experience as Head of Accreditation and the journey to Kiang Wu Nursing College of Macau becoming the first ADI Accredited body.
ADI attends the 150th session of the WHO Executive Board
ADI delivered important statements to the World Health Organization (WHO) and Member States on the importance of considering those living with dementia and carers in pandemic responses, humanitarian crises, as well as a new neurological global action plan.
Support, encourage, empower: Leading the way towards a dementia friendly community in Australia
In this blog from Maree McCabe, CEO of Dementia Australia, Maree writes about the organisation's dementia friendly communities programme and how people living with dementia are spearheading its success.
CMS confirms eligible clinical trial requirement to access Aduhelm in the US
The Centers for Medicare & Medicaid Services (CMS) in the US confirms requirement for clinical trials to access Aduhelm but broadens which trials are eligible.